BioSpace News Archive

Individuals with prediabetes who participate in an employer-sponsored digital diabetes-prevention counseling program may reduce their risk of developing type 2 diabetes (T2D) for up to eight years, according to a new study from Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services.

Company enters multi-year agreement with Columbia-based Procaps to conduct advanced manufacturing in Latin America

Jazz Pharmaceuticals plc announced that the U.S. Drug Enforcement Agency has designated solriamfetol, also known as Sunosi, as a Schedule IV medicine.

Nuvo Pharmaceuticals Inc. provided a corporate update on various matters including its VIMOVO patents, the identification of Aralez Transaction synergies and an update regarding the status of its financing arrangements with Deerfield Management Company, L.P..

On Saturday, June 1st, Children’s Dental Health celebrated the official grand opening of its first Wilmington, Delaware office at 3301 Lancaster Pike, mere hours after announcing its acquisition of a second Wilmington office located at 708 Foulk Road.

A Feline-Friendly Breakthrough for Neutralizing Fel d1, the Major Cat Allergen

$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel

U.S. Patent and Trademark Office issued three U.S. patents covering certain anti-CD137 antibodies, including its lead therapeutic candidate, CTX-471.

China Jo-Jo Drugstores, Inc. announced that the Company hosted a reception for Mr. Li Keqiang, the Prime Minister of the People’s Republic of China on June 12, 2019.

IVM is a powerful tool enabling real-time in vivo visualization of important immune activation and movements in tumor microenvironment driven by TAVO-PLUS